In addition, there is an urgent need to understand the impact of cancer-specific mutations in MAGEA6 on tumor aggressiveness and on immunotherapy strategies (Caballero et al., 2010; Hagiwara et al., 2016). This evidence concerns the gene MAGEA6 and neoplasm.